B7-1(CD80)-transfected human glioma cells and interleukin-12 directly stimulate allogeneic CD8+ T cells

Journal of Immunotherapy

Volumn 20, Issue 4, 1997, Pages 256-264

  Komata, Tadashi ^a   Tanaka, Ryuichi ^a   Yamamoto, Kiyoshi ^a   Oda, Tazunu ^a   Ono, Koji ^a   Yoshida, Seiichi ^a   Takahashi, Masuhiro ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

B7 1 (CD80); Costimulatory molecule; Cytotoxic activity; Human glioma cells; Interleukin 12

Indexed keywords

B7 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; EFFECTOR CELL; GENETIC TRANSFECTION; GLIOMA CELL; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MIXED LYMPHOCYTE CULTURE; NATURAL KILLER CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, CD80; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-12; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031464925     PISSN: 10538550     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002371-199707000-00002     Document Type: Article

References (19)

1. Chen L, Ashe S, Brady WA, et al. Costimulation of anti-tumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA4. Cell 1992;71:1093-102.
2. Baskar S, Ostrand-Rosenberg S, Nabavi N, Nadler LM, Freeman GJ, Glimcher LH. Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules. Proc Natl Acad Sci U S A 1993;90:5687-90.
3. + cytotoxic T lymphocytes in the absence of exogenous help. J Exp Med 1993:177:1791-6.
4. + T cells by B7-transfected melanoma cells. Science 1993;259:368-70.
5. Van Gool SW, Mark de Boer, Ceuppens JL. CD28 ligation by monoclonal antibodies or B7/BB1 provides an accessory signal for the cyclosporin A-resistant generation of cytotoxic T cell activity. J Immunol 1993;150:3254-63.
6. Murphy EE, Terres G, Macatonia SE, et al. B7 and interleukin 12 cooperate for proliferation and interferon (production by mouse T helper clones that are unresponsive to B7 costimulation. J Exp Med 1994;180:223-31.
7. Gajewski TF, Renauld J-C, Van Pel A, Boon T. Costimulation with B7-1, IL-6, and IL-12 is sufficient for primary generation of murine antitumor cytolytic T lymphocytes in vitro. J Immunol 1995; 154:5637-48.
8. Coughlin CM, Wysocka M, Kurzawa HL, Lee WMF, Trinchieri G, Eck SL. B7-1 and interleukin 12 synergistically induce effective antitumor immunity. Cancer Res 1955;55:4980-7.
9. Glasebrook AL, Fitch FW. T-cell lines which cooperate in generation of specific cytolytic activity. Nature 1979;278:171-3.
10. Buller RML, Holmes KL, Hügin A, Frederickson TN, Morse HC III. Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells. Nature 1987;328:77-9.
11. Bunce M, O'Neill CM, Barnardo MCNM, et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995;46:355-67.
12. Yoshida M, Kimura A, Numano F, Sasazuki T. Polymerase-chain-reaction-based analysis of polymorphism in the HLA-B gene. Hum Immunol 1992;34:257-66.
13. Fernandez-Viña, Lazaro AM, Sun Y, Miller S, Forero L, Stastny P. Population diversity of B-locus alleles observed by high-resolution DNA typing. Tissue Antigens 1995;45:153-68.
14. Hopkins KA. Basic microlymphocytotoxicity test. In: ASHI laboratory manual. 2nd ed. American Society for Histocompatibility and Immunogenetics, 1990:195-201.
15. Marincola FM, Shamamian P, Simonis TB, et al. Locus-specific analysis of human leukocyte antigen class I expression in melanoma cell lines. J Immunother 1994;6:13-23.
16. Kubin M, Kamoun M, Trinchieri G. Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. J Exp Med 1994;180:211-22.
17. + T lymphocytes. J Immunol 1993;151:2444-52.
18. Tahara H, Zeh HJ III, Storkus WJ, et al. Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo. Cancer Res 1994;54:182-9.
19. Chambers BJ, Salcedo M, Ljunggren H-G. Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1). Immunity 1996;5:311-7.